The Role of Tumor Grades in Cancer Treatment
When diagnosed with breast cancer, patients often encounter medical terms that can feel overwhelming, including the concept of tumor grades. Tumor grading is a critical part of understanding a cancer diagnosis, as it provides insight into how abnormal the cancer cells appear and how aggressively they may grow and spread. Unlike staging, which focuses on the size and extent of the tumor, grading looks at the cellular level to guide treatment decisions. This article will break down what tumor grades mean, their role in shaping personalized treatment plans, and innovations in the tumor-grading process.
By Tuna Önel | Editorial Director of MammogramMe
Published February 19, 2025
Wednesday Weekly
What Are Tumor Grades?
-
Tumor grades classify cancer cells based on how abnormal they look under a microscope and how likely they are to grow and spread. Unlike cancer staging, which assesses the tumor’s size and whether it has spread, grading focuses on the microscopic characteristics of cancer cells. The most widely used system for grading breast cancer is the Nottingham Grading System, which evaluates tumors based on three key factors: tubule formation, which measures how much of the tumor retains normal breast tissue structures; nuclear pleomorphism, which assesses how abnormal the cell nuclei appear; and mitotic count, which determines how quickly the cells are dividing. Each of these factors is assigned a score from 1 to 3, and the total score (ranging from 3 to 9) determines the tumor grade.
-
​ A Grade 1 (low-grade) tumor has cells that look more like normal breast tissue, grow slowly, and are less likely to spread. Grade 2 (intermediate-grade) tumors have more abnormalities in their structure and tend to grow at a moderate pace. Grade 3 (high-grade) tumors appear very different from normal cells, grow rapidly, and have a higher likelihood of spreading. Pathologists determine a tumor’s grade by analyzing a biopsy sample, and this information is crucial for understanding the cancer’s behavior and potential aggressiveness.
The Role of Tumor Grades in Treatment and Prognosis
-
Understanding tumor grades plays a role in treatment planning. A low-grade (Grade 1) tumor grows slowly and may only require localized treatments such as surgery or radiation. If the cancer is hormone receptor-positive, hormone therapy may be recommended as well. Intermediate-grade (Grade 2) tumors require a more tailored approach, often combining surgery, radiation, and possibly chemotherapy. High-grade (Grade 3) tumors, due to their aggressive nature, are more likely to require intensive treatment, including chemotherapy, targeted therapy, or immunotherapy.
-
Beyond treatment, tumor grades also provide insight into prognosis. Studies show that high-grade tumors tend to have a higher recurrence rate, but they may also respond better to chemotherapy due to their rapid cell division. Advances in personalized medicine, including genomic testing (Oncotype DX, MammaPrint), provide additional insights into a tumor’s likelihood of recurrence and whether chemotherapy is necessary, supplementing traditional grading. While higher-grade tumors may be more challenging, targeted therapies such as Herceptin (trastuzumab) for HER2-positive tumors have significantly improved survival rates. Understanding tumor grades allows doctors to recommend the most effective treatment while balancing the potential side effects and risks for each patient.
Emerging Research and Advanced Testing
-
New technologies are improving how tumor grades are assessed and used in treatment planning. Genomic testing (Oncotype DX, MammaPrint) provides a deeper understanding of cancer behavior, supplementing traditional grading by predicting recurrence risk. These tests analyze the genetic makeup of the tumor, helping doctors determine whether chemotherapy is necessary or if hormone therapy alone will be sufficient. Additionally, liquid biopsies, which detect tumor DNA in the bloodstream, are being explored as a potential way to monitor cancer progression in real-time without the need for invasive procedures. AI-assisted pathology is also being developed to enhance accuracy in tumor grading and identify subtle differences in cancer cell characteristics that may not be easily detected by human observation.